Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/11691
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPratesi, Alessandro-
dc.contributor.authorCIRRI, DAMIANO-
dc.contributor.authorĐurović, Mirjana-
dc.contributor.authorPillozzi S.-
dc.contributor.authorPetroni, Giulia-
dc.contributor.authorBugarčić, Živadin-
dc.contributor.authormessori, luigi-
dc.date.accessioned2021-04-20T18:59:34Z-
dc.date.available2021-04-20T18:59:34Z-
dc.date.issued2016-
dc.identifier.issn0966-0844-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/11691-
dc.description.abstract© 2016, Springer Science+Business Media New York. Three structurally related gold(I) carbene complexes with bulky hydrophobic ligands i.e. 1–3 were investigated in solution for further consideration as candidate anticancer agents. Cytotoxic assays were subsequently conducted on bone marrow-derived preosteoclast cell line of human origin (FLG 29.1) and human colon cancer cells (HCT-116). A far greater cytotoxic activity was measured for compound 1 against HCT-116 cells compared to 2 and 3; conversely, all compounds were highly and similarly active against FLG 29.1 cells. Results obtained for the reaction of complexes 1 and 2 with RNase A documented the occurrence of a weak interaction with this model protein and the formation of a tiny amount of the corresponding adduct. Moreover, a certain reactivity of the complex 2 was also detected toward GSH. The general implications of the obtained results are discussed.-
dc.rightsrestrictedAccess-
dc.sourceBioMetals-
dc.titleNew gold carbene complexes as candidate anticancer agents-
dc.typearticle-
dc.identifier.doi10.1007/s10534-016-9962-0-
dc.identifier.scopus2-s2.0-84983000184-
Appears in Collections:Faculty of Science, Kragujevac

Page views(s)

100

Downloads(s)

4

Files in This Item:
File Description SizeFormat 
PaperMissing.pdf
  Restricted Access
29.86 kBAdobe PDFThumbnail
View/Open


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.